Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Here's why McDonald's is more exposed than other fast-food brands to shifts in eating habits as a result of weight-loss drugs ...

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.

ABC News' Dr. Tara Narula explains a new study indicating that stopping GLP 1 weight loss medications too soon could make it harder to lose weight.